De Vane CL, Liston HL, Markowitz JS
However, these results also introduce a practical challenge: the risk of cross-resistance when patients receive more than one ADC with the same payload mechanism
Tirzepatide Tirzepatide is a dual GIP and GLP-1 receptor agonist used to treat type II diabetes in adults as an adjunct to diet and exercise
The development of oral glucagon like peptide 1 analogs offers a transformative opportunity to enhance patient convenience, improve compliance, and expand the target demographic, particularly among individuals with needle aversions or injection phobia
Beyond its role in sleep regulation, DSIP has been investigated for its potential applications in other health areas
In rodent models, it promotes lipolysis by converting stored fat into free fatty acids without stimulating GH pathways, including IGF-1